Andere Kunden interessierten sich auch für
![Molecular Approach to Cancer Management]( "Molecular Approach to Cancer Management")
Molecular Approach to Cancer Management208,99 €![Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy]( "Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy")
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy182,99 €![Translational Cancer Research for Surgeons, an Issue of Surgical Oncology Clinics]( "Translational Cancer Research for Surgeons, an Issue of Surgical Oncology Clinics")
Translational Cancer Research for Surgeons, an Issue of Surgical Oncology Clinics114,99 €![Breast Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Breast Cancer, an Issue of Hematology/Oncology Clinics of North America")
Breast Cancer, an Issue of Hematology/Oncology Clinics of North America114,99 €![Immune Checkpoint Inhibitors in Cancer]( "Immune Checkpoint Inhibitors in Cancer")
Immune Checkpoint Inhibitors in Cancer115,99 €![Chimeric Antigen Receptor T-Cell Therapies for Cancer]( "Chimeric Antigen Receptor T-Cell Therapies for Cancer")
Chimeric Antigen Receptor T-Cell Therapies for Cancer93,99 €![Breast Cancer, an Issue of Surgical Oncology Clinics of North America]( "Breast Cancer, an Issue of Surgical Oncology Clinics of North America")
Breast Cancer, an Issue of Surgical Oncology Clinics of North America114,99 €
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.
Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. Includes a timely section on innovative future therapies.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. Includes a timely section on innovative future therapies.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.